Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint
This article is from
The Cancer Letter
archive.
Vol. 34 No. 11 | November 25, 2011
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Proteomics Used To Find Predictor Of Response In FAP
April 30, 2004
TCL Archive
Fruits, Vegetables Protective Against Cancer, IARC Says
May 30, 2003
TCL Archive
NIH Awards 24 More Grants For Women’s Health Initiative
October 14, 1994
TCL Archive
Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.
July 28, 2006
TCL Archive
Letter: ORI And Plotkin Should Release Report
June 23, 1995
TCL Archive
ACS California Division Offers Fellowships For Clinical Research
June 14, 1996